Clinical Research Studies

The goal of this study is to assess the immune response, tolerance, and safety of the low-dose intradermal (forearm) mpox vaccine in people who are HIV+ compared to people who are HIV-, and compared to the standard-dose subcutaneous (upper arm) vaccine. The resulting data will fill knowledge gaps, inform public health practices, and address community concerns about the absence of data for low-dose intradermal mpox vaccinations in people living with HIV.

This is an observational study, meaning there is no clinical intervention. Participants will be asked to provide blood and saliva samples at up to 5 visits over the next year.

Participants may receive 85$ per visit.